http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Catherine M. Otto (검색결과 1 건)
- 무료
- 기관 내 무료
- 유료
-
Aortic Stenosis: Changing Disease Concepts
Nina Rashedi,Catherine M. Otto 한국심초음파학회 2015 Journal of Cardiovascular Imaging (J Cardiovasc Im Vol.23 No.2
Aortic stenosis (AS) occurs in almost 10% of adults over age 80 years with a mortality about 50% at 2 years unless outflowobstruction is relieved by aortic valve replacement (AVR). Development of AS is associated with anatomic, clinical and geneticrisk factors including a bicuspid valve in 50%; clinical factors that include older age, hypertension, smoking, diabetes andelevated serum lipoprotein(a) [Lp(a)] levels; and genetic factors such as a polymorphism in the Lp(a) locus. Early stages of AS arecharacterized by focal areas of leaflet thickening and calcification. The rate of hemodynamic progression is variable but eventualsevere AS is inevitable once even mild valve obstruction is present. There is no specific medical therapy to prevent leaflet calcification. Basic principles of medical therapy for asymptomatic AS are patient education, periodic echocardiographic and clinicalmonitoring, standard cardiac risk factor evaluation and modification and treatment of hypertension or other comorbid conditions. When severe AS is present, a careful evaluation for symptoms is needed, often with an exercise test to document symptom statusand cardiac reserve. In symptomatic patients with severe AS, AVR improves survival and relieves symptoms. In asymptomaticpatients with severe AS, AVR also is appropriate if ejection fraction is < 50%, disease progression is rapid or AS is very severe(aortic velocity > 5 m/s). The choice of surgical or transcatheter AVR depends on the estimated surgical risk plus other factorssuch as frailty, other organ system disease and procedural specific impediments.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
